Stockscreener 앱 받기
0.742
4.26%
-0.033
시장 영업 전:
.74
-0.002
-0.27%
전일 마감가:
$0.775
열려 있는:
$0.74
하루 거래량:
206.57K
Relative Volume:
0.24
시가총액:
$3.60M
수익:
-
순이익/손실:
$-39.62M
주가수익비율:
-0.000449
EPS:
-1654.3275
순현금흐름:
$-17.96M
1주 성능:
-12.45%
1개월 성능:
-62.99%
6개월 성능:
-98.32%
1년 성능:
-99.86%
1일 변동 폭
$0.7301
$0.7945
1주일 범위
$0.6859
$0.87
52주 변동 폭
$0.6859
$610.00
Cdt Equity Inc Stock (CDT) Company Profile
명칭
Cdt Equity Inc
전화
(646) 491 9132
주소
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
0.742 | 3.77M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
445.77 | 112.43B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
616.18 | 64.09B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.00 | 54.88B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.69 | 39.01B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
149.55 | 31.57B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cdt Equity Inc 주식(CDT)의 최신 뉴스
CDT Equity receives Nasdaq notice over delayed quarterly filing - MSN
CDT and Liam Moor Acquire Atlantic at Twin Hickory to Preserve Affordable Senior Homes in Glen Allen, Va - Weekly Voice
[SCHEDULE 13G] CDT Equity Inc. Passive Investment Disclosure (>5%) - Stock Titan
CDT Equity Surges As AZD5904 Patent Wins Drive Speculation - timothysykes.com
CDT Equity Company Profile & Introduction - Moomoo
CDT Equity AZD5904 Patents Power Bullish Trading Setup - timothysykes.com
CDT Equity Jumps As AZD5904 Patent Wins Fuel Deal Hopes - StocksToTrade
CDT Equity Jumps As AZD5904 Patent Wins Fuel Licensing Hopes - StocksToTrade
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
CDT Faces Nasdaq Compliance Notice Due to Filing Delay - GuruFocus
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter - Moomoo
CDT Equity Receives Nasdaq Notice Over Late Filing - TipRanks
CDT Equity Inc. Receives Nasdaq Deficiency Letter for Non-Compliance - geneonline.com
CDT Equityhas until July 20, 2026 to submit Nasdaq compliance plan - marketscreener.com
Nasdaq warns CDT Equity (CDT) over delayed Form 10-Q but trading continues - Stock Titan
CDTTW Warrants Remain at Floor Level – CDT Equity Inc. (CDTTW) Shows No Price MovementArms Index - The Legal Advocate
CDT Environmental Technology Investment Holdings Limited Announces Share Consolidation - Yahoo Finance
CDTTW Warrants Trade Flat at $0.01 Amidst Minimal ActivityOverbought Signal Alerts - The Legal Advocate
CDT Equity Inc. Warrant (CDTTW) Holds at $0.01 – A Penny Stock at a Trading CrossroadsGap and Go - The Legal Advocate
CDT Equity receives Canadian patent for male infertility drug By Investing.com - Investing.com Nigeria
CDT Equity receives Canadian patent for male infertility drug - Investing.com
No approved drugs for male infertility — but CDT just secured a key patent - Stock Titan
CDTTW Warrants Remain Static at $0.01 – Analysis of Current StalemateShort Term Trading Ideas - The Legal Advocate
CDT Equity Inc. Warrant (CDTTW) Holds at $0.01 – Minimal Movement Amid Thin TradingDelta Hedging - The Legal Advocate
CDT Equity Inc. (CDT) Falls Sharply: Key Support Levels in Focus After 13.9% DeclineMomentum Stock Picks - The Legal Advocate
CDT Equity Inc. (CDT) Plunges 14% as Selling Pressure Intensifies Below $1.10 ResistanceNaked POC - Newser
Nirland-controlled group reports 75,315 CDT shares (NASDAQ: CDT) - Stock Titan
Equity Inc (CDT) Stock Analysis: Climbs +3.33%, Eyes on $1.30 2026-05-20Social Trading Insights - Newser
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market SessionAIM ImmunoTech (AMEX:AIM), Atlantic Inter - Benzinga
CDT Equity Flags Delay in Quarterly Filing - TipRanks
CDT Equity Modifies Financing Agreements to Boost Liquidity - TipRanks
CDT Equity (NASDAQ: CDT) notifies SEC of delayed Q1 2026 10-Q; plans filing - Stock Titan
Cdt Equity Inc enters amendment no. 2 to equity line of credit facility on May 15, 2026SEC filing - marketscreener.com
CDT Equity Inc. (NASDAQ: CDT) tweaks equity line and note proceeds - Stock Titan
Corvus updates CDT Equity (CDT) ownership to about a 5.4% stake - Stock Titan
CEO-linked entities of CDT Equity (CDT) add shares, exercise warrants - Stock Titan
Purple Innovation (PRPL) Stock Today: Drops -6.80%, Key Support at $0.41 2026-05-14Volume Rate Change - The Legal Advocate
Number of shareholders of CDT Equity Inc. – NASDAQ:CDT - TradingView
CDT Equity Advances AstraZeneca PLC (AZN)’s AZD5904 Into PCT Patent Protection Stage - Yahoo Finance
CDT SEC FilingsCDT Equity 10-K, 10-Q, 8-K Forms - Stock Titan
CDT Equity Inc shares plunge 7.96% as Q1 2026 shows zero revenue and massive loss.EBIT Margin - Newser
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - The Manila Times
A patent filed in under 3 weeks puts CDT's Sarborg stake in focus - Stock Titan
Cdt Equity Inc (CDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.97%
자본화:
|
볼륨(24시간):